<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Integrated Genomics, Inc. The contract, valued at $5,000.00, is for "TAS::75 0885::TAS G. LAMBLIA STRAINS INTEGRATED GENOMICS, INC. (AMBIS #1529649)" and was awarded on October 21, 2010 with a completion date of November 30, 2010. The contract does not have a set-aside designation.</p>
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Integrated Genomics, Inc. for ORF identification, annotation, and ERGO update services. The contract has a ceiling value of $11,999.90 and was awarded on October 29, 2010 with a final completion date of December 30, 2010. The contract does not have a set-aside designation. Based on the agency and...
<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IG Assets Inc. for the preparation of GenBank submission files for two eukaryotic genomes, with a ceiling value of $8,000.00 and a completion date of November 23, 2011. The contract does not have a set-aside designation.</p>
This $5,000.00 Firm Fixed Price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to IG Assets Inc. The contract is for the automated annotation of the Staphylococcus genome, including uploading the annotated data to the ERGO server and preparing and submitting the data to GenBank. The contract does not have a set-aside designation and was awarded on March 29, 2011, with a completion date...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to IG Assets Inc. for the manual annotation of the Giardia genome in the ERGO database. The contract has a firm fixed price of $4,999.00 and a completion date of August 1, 2012. The contract is a purchase order and does not have a set-aside designation. The provided information does not indicate any major subcontractors for...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Integrated Genomics, Inc. The contract, valued at $9,950.00, is for the custom gene aliasing of Borrelia genomes. The contract has no set-aside designation and the period of performance ends on July 7, 2010. This contract appears to be related to NIAID's research activities, which include studying infectious diseases such as those caused by Borrelia bacteria.</p>
<p>This is a Firm Fixed Price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) division of the Department of Health and Human Services (HHS) to IG Assets Inc. for GenBank submission of 5 Borrelia genomes. The contract has a ceiling value of $10,000.00 and was awarded on March 1, 2013 with a completion date of March 7, 2013. This contract does not have a set-aside designation.</p>
<p>This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Igenbio Inc. for the annotation of 5 Granulibacter spp genomes. The contract has a total ceiling value of $12,500.00 and was awarded on November 18, 2014, with a final completion date of November 19, 2014. The contract does not have a set-aside designation. Igenbio Inc. is a minority-owned, self-certified small disadvantaged business.</p>
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to IG Assets Inc. for $5,000.00. The contract is for ORF calling, annotation, upload to RML server, and GenBank preparation and submission for 1 Staphylococcus genome. The contract has an ultimate completion date of July 25, 2011 and was awarded on June 7, 2011. No set-aside designation was used for this contract.</p>
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geospiza, Inc., a for-profit manufacturer of goods. The contract has a ceiling value of $12,075.00 and a period of performance ending on March 31, 2012. There is no set-aside designation for this contract. The award is not associated with a larger vehicle. Based on the product/service description, this...